覆膜支架治疗12例假性动脉瘤的体会  

Treatment of pseudoaneurysms with stent-graft: preliminary experience in 12 cases

作　　者：廖登辉[1] 叶财盛[1] 李松奇[1] 叶润仪[1] 常光其[1] 陈伟[2] 李晓曦[1] 王深明[1] 

机构地区：[1]广州中山大学附属第一医院血管甲状腺外科,510080 [2]广州中山大学附属第一医院血放射介入科,510080

出　　处：《介入放射学杂志》2012年第5期374-376,共3页Journal of Interventional Radiology

摘　　要：目的评估覆膜支架治疗假性动脉瘤的疗效。方法 2008年3月至2011年6月收治假性动脉瘤患者86例,其中12例采用覆膜支架腔内治疗。发病部位在胸主动脉4例,腹主动脉3例(1例肾上型,2例肾下型),颈总动脉3例,颈内动脉1例,右锁骨下动脉1例。术后对12例患者的疗效进行观察,并随访5～43个月。结果支架释放技术成功率为100%,所有12例假性动脉瘤植入覆膜支架后被立即隔绝,无内漏,载瘤动脉远端血流通畅。除1例失访外,其余11例平均随访23.5个月。1例合并白塞病患者术后4个月因腹主动脉破裂大出血死亡,其余10例随访结果良好,支架无狭窄、无移位、无内漏等相关并发症。结论应用覆膜支架治疗假性动脉瘤近期疗效良好,但远期疗效还需进一步观察。Objective To assess the clinical effect of stent-graft in the treatment of pseudoaneurysms. Methods During the period from March 2008 to June 2011, 86 patients with pseudoaneurysm were admitted to the hospital, of whom stent-graft implantation was carried out in 12. The pseudoaneurysms were located at the thoracic aorta （n = 4）, abdominal aorta （n = 3）, common carotid artery （n = 3）, internal carotid artery （n = 1） and right subclavian artery （n = 1）. All the patients were followed up for 5 - 43 months. The clinical results were analyzed. Results The technical success rate for stent delivery was 100%. The pseudoaneurysm was immediately isolated after the procedure in all 12 cases. After endovascular exclusion with stent-graft, no leakage occurred and the blood flow distal to the parent artery was normal. All patients were followed up for a mean period of 23.5 months except one who lost in touch with the authors. One patient with coexisting Behcet＇s disease died of massive bleeding due to abdominal aortic rupture four months after operation. The other patients were in good clinical condition, and no complications such as stent stenosis, displacement, internal leakage, etc. were observed in the follow-up period. Conclusion The implantation of stent-graft has satisfactory short-term effect in treating pseudoaneurysms, although its long-term efficacy needs to be further observed.

关 键 词：假性动脉瘤 覆膜支架 腔内隔绝术 

分 类 号：R543.5[医药卫生—心血管疾病]